powder for solution for infusion clinical trials
3 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Phase 3, Open-Label, Randomized, Active-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib Versus Gemcitabine Plus Cisplatin Chemotherapy in First-Line Treatment of Participants With Unresectable or Metastatic Cholangiocarcinoma With FGFR2 Rearrangement (FIGHT-302)
This study is testing a new drug, pemigatinib, against standard chemotherapy for a type of bile duct cancer (cholangiocarcinoma) that has spread or can't be removed, and has a specific gene change. It wants to see which treatment works better and is safer as a first treatment.
For: CholangiocarcinomaGermany · Belgium · Italy - Ongoing, recruitingTherapeutic use (Phase IV)
Effects of Digoxin in Modern Heart Failure Treatment
This study looks at how well the medicine Digoxin works for people with heart failure. It checks how much oxygen your body uses during exercise and how well your heart pumps, to understand its effects in modern treatments.
For: Heart FailurePortugal - AuthorisedTherapeutic exploratory (Phase II)
Osteoarticular infections on equipment: impact of three probabilistic antibiotic therapy strategies on the digestive microbiota and gastrointestinal colonization with multidrug-resistant bacteria
This study looks at how different antibiotic treatments for bone and joint infections affect the helpful germs in your gut. We want to see which treatments cause fewer problems with harmful, drug-resistant bacteria developing in your digestive system.
For: Osteoarticular infections on equipmentFrance